Investigation of rifampicin-induced hepatotoxicity in rat hepatocytes maintained in gel entrapment culture

被引:19
作者
Shen, Chong [1 ]
Cheng, Xiangdong [2 ]
Li, Donghui [3 ]
Meng, Qin [1 ]
机构
[1] Zhejiang Univ, Coll Mat Sci & Chem Engn, Hangzhou 310027, Zhejiang, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China
[3] Red Cross Hosp, Hangzhou 310003, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Gel entrapment; Hepatocyte monolayers; Hepatotoxicity; Rat hepatocytes; Rifampicin; INDUCED HEPATIC-INJURY; CYTOCHROME-P450; INDUCTION; INDUCED CYTOTOXICITY; ENERGY MALNUTRITION; OXIDATIVE-STRESS; YOUNG-RATS; IN-VITRO; LIVER; METABOLISM; PHARMACOKINETICS;
D O I
10.1007/s10565-008-9076-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Rifampicin-induced hepatotoxicity has been well recognized in animals and patients. However, it is undetectable in cultured hepatocyte monolayers in vitro at the equivalent toxic concentration in vivo. This study investigated the rifampicin-induced toxicity on rat hepatocytes in gel entrapment vs. in monolayer culture. Thiazolyl tetrazolium reduction and albumin secretion were routinely detected to identify the toxic responses of rat hepatocytes to rifampicin, while reactive oxygen species (ROS) accumulation and intracellular glutathione (GSH) content were assayed as biomarkers of oxidative stress. In addition, Nile red staining and malondialdehyde (MDA) generation were, respectively, used as endpoints for lipid accumulation and peroxidation. After treatment of hepatocytes for 96 h at a serum rifampicin concentration (12 mu M), gel-entrapped rat hepatocytes showed significant cellular damage indicated by alternations of all parameters indicated above, while hepatocyte monolayers did not show severe responses. In contrast to a lack of protections by cytochrome P 450 inhibitors, the ROS scavenger (glycyrrhizic acid) and thiol compounds (N-acetylcysteine and GSH) significantly reduced rifampicin toxicity in gel-entrapped hepatocytes. It appears that gel-entrapped rat hepatocytes reflected significant hepatotoxicity of rifampicin in vivo, and this toxicity was most possibly associated with oxidative stress and lipid accumulation.
引用
收藏
页码:265 / 274
页数:10
相关论文
共 44 条
[1]   CLINICAL PHARMACOKINETICS OF RIFAMPICIN [J].
ACOCELLA, G .
CLINICAL PHARMACOKINETICS, 1978, 3 (02) :108-127
[2]  
ADACHI Y, 1985, Gastroenterologia Japonica, V20, P104
[3]   PHARMACOKINETIC STUDIES OF RIFAMPICIN IN THE ELDERLY [J].
ADVENIER, C ;
GOBERT, C ;
HOUIN, G ;
BIDET, D ;
RICHELET, S ;
TILLEMENT, JP .
THERAPEUTIC DRUG MONITORING, 1983, 5 (01) :61-65
[4]   LIVER TOXICITY OF COMBINED RIFAMPICIN-ISONIAZID-ETHAMBUTOL MEDICATION [J].
AUSTERHOFF, A ;
KINDLER, U ;
KNOP, P ;
KNIERIEM, HJ .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1974, 99 (22) :1182-1188
[5]   Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes:: Protection by N-acetyl cysteine [J].
Bajt, ML ;
Knight, TR ;
Lemasters, JJ ;
Jaeschke, H .
TOXICOLOGICAL SCIENCES, 2004, 80 (02) :343-349
[6]   An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons [J].
Brandon, EFA ;
Raap, CD ;
Meijerman, I ;
Beijnen, JH ;
Schellens, JHM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 189 (03) :233-246
[7]   FLUVOXAMINE IS A POTENT INHIBITOR OF CYTOCHROME-P4501A2 [J].
BROSEN, K ;
SKJELBO, E ;
RASMUSSEN, BB ;
POULSEN, HE ;
LOFT, S .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (06) :1211-1214
[8]   The effect of pyrazinamide and rifampicin on isoniazid metabolism in rats [J].
De Rosa, Helene J. ;
Baldan, Helen M. ;
Brunetti, Iguatemy L. ;
Ximenes, Valdecir F. ;
Machado, Rosangela G. P. .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2007, 28 (06) :291-296
[9]   Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts [J].
Donato, M. Teresa ;
Lahoz, Agustin ;
Jimenez, Nuria ;
Perez, Gabriela ;
Serralta, Alfonso ;
Mir, Jose ;
Castell, Jose V. ;
Gomez-Lechon, M. Jose .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (09) :1556-1562
[10]   Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors [J].
Granville, DJ ;
Tashakkor, B ;
Takeuchi, C ;
Gustafsson, AB ;
Huang, CQ ;
Sayen, MR ;
Wentworth, P ;
Yeager, M ;
Gottlieb, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (05) :1321-1326